<div id="readability-page-1">Crispr Therapeutics (CRSP) pared a loss amid some takeover speculation. There's speculation that a takeover bid for Crispr (CRSP) could be moving along as the potential buyer has hired an adviser to help with a bid, according to traders, who cited a Betaville &#34;uncooked&#34; alert that was circulating on Monday. People following the matter have heard ta...</div>

CRSP

<p>Crispr Therapeutics (CRSP) is experiencing takeover speculation, with reports suggesting a potential buyer has hired an adviser and possibly law firm Skadden for a bid. Betaville previously indicated interest from a US-based biopharma with a market cap of $100-$200 billion. Traders are closely monitoring developments.</p>

Crispr Therapeutics pares loss amid takeover speculation